Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC2683249

Invivogen diABZI (Compound 3): Potent Non-CDN STING Agonist, Increased Bioavailability, Validated Purity, 2 mg
SDP

Catalog No. NC2683249
Encompass

diABZI is a potent non-canonical STING agonist that activates NF-κB and IRF pathways, enhancing immune responses. It offers increased bioavailability compared to classical STING agonists, making it a potential therapeutic for cancer and viral infections, such as SARS-CoV-2. With validated purity and precise working concentration (0.01 - 30 µM), diABZI can effectively induce type-I interferons and pro-inflammatory cytokines, providing promising treatment avenues for various conditions.

Catalog No. NC2683249 Supplier Invivogen Supplier No. TLRLDIABZI2
May include imposed supplier surcharges.
Add to Cart
Add to Cart

diABZI is a potent non-canonical STING agonist that activates NF-κB and IRF pathways, enhancing immune responses. It offers increased bioavailability compared to classical STING agonists, making it a potential therapeutic for cancer and viral infections, such as SARS-CoV-2. With validated purity and precise working concentration (0.01 - 30 µM), diABZI can effectively induce type-I interferons and pro-inflammatory cytokines, providing promising treatment avenues for various conditions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.